Evidence map›Paper›PMID 29311089›Full record

ArticleAntimicrobial agents and chemotherapy2018

Molecular Characterization of IMP-1-Producing Enterobacter cloacae Complex Isolates in Tokyo.

Kotaro Aoki, Sohei Harada, Koji Yahara, Yoshikazu Ishii, Daisuke Motooka, Shota Nakamura, Yukihiro Akeda, Tetsuya Iida, Kazunori Tomono, Satoshi Iwata and 2 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. Complete genome sequence of a carbapenem-resistantMicrobiology resource announcements · 2026
    Article
  3. Article
  4. High-risk clonal expansion of IMP-producingAntimicrobial agents and chemotherapy · 2025
    Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. A case of community-acquired pneumonia caused byRespirology case reports · 2024
    Article
  13. Article
  14. Molecular Epidemiology of Carbapenem-ResistantInternational journal of molecular sciences · 2024
    Article
  15. Analysis of the stepwise acquisition ofJAC-antimicrobial resistance · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Microbiology spectrum · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Kotaro AokiDepartment of Microbiology and Infectious Diseases, Toho University Graduate School of Medicine, Tokyo, Japan.
Sohei HaradaDepartment of Microbiology and Infectious Diseases, Toho University Graduate School of Medicine, Tokyo, Japan.
Koji YaharaAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Higashimurayama, Tokyo, Japan.
Yoshikazu IshiiDepartment of Microbiology and Infectious Diseases, Toho University Graduate School of Medicine, Tokyo, Japan yishii@med.toho-u.ac.jp.
Daisuke MotookaResearch Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Shota NakamuraResearch Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Yukihiro AkedaDepartment of Infection Control and Prevention, Osaka University School of Medicine, Osaka, Japan.
Tetsuya IidaResearch Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Kazunori TomonoDepartment of Infection Control and Prevention, Osaka University School of Medicine, Osaka, Japan.
Satoshi IwataDepartment of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
Kyoji MoriyaDepartment of Infection Control and Prevention, University of Tokyo Hospital, Tokyo, Japan.
Kazuhiro TatedaDepartment of Microbiology and Infectious Diseases, Toho University Graduate School of Medicine, Tokyo, Japan.
Osaka University · JPToho University · JPKeio University · JPNational Institute of Infectious Diseases · JPUniversity of Tokyo Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although KPC enzymes are most common among carbapenemases produced by

Indexed as

Anti-Bacterial Agentsbeta-Lactamasesbeta-Lactam ResistanceCarbapenemsEnterobacterEnterobacter cloacaeEnterobacteriaceae InfectionsGene ExpressionHospitalsHumansMicrobial Sensitivity TestsMolecular EpidemiologyPhylogenyPlasmidsTokyoWhole Genome SequencingAnti-Bacterial Agentsbeta-lactamase IMP-1beta-LactamasesCarbapenemscarbapenemase-producing EnterobacteriaceaeEnterobacter cloacae complexIMP-1metallo-β-lactamaseplasmidwhole-genome sequencing

Identifiers

PMID29311089
PMCPMC5826111
OpenAlexW2783061523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.